[1] | Hossny EM, Hasan ZE, Allam MF and Mahmoud ES (2009). Analysis of the filed data of a sample of Egyptian children with bronchial asthma. Egypt J Pediatr Allergy Immunol; 7(2):59-64. |
[2] | Masoli M, Fabian D, Holt S, Beasley R (2004). Global initiative for asthma (GINA) program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy; 59:469-78. |
[3] | Szefler SJ (2008). Asthma progression: Can we and should we measure it? Journal of Allergy and Clinical mmunology; 121:598-600. |
[4] | Miller RL, Garfinkel R, Lendor C, Hoepner L, Li Z, Romanoff L, Sjodin A, Needham L, Perera FP, Whyatt RM (2010). Polycyclic aromatic hydrocarbon metabolite levels and pediatric allergy and asthma in an inner-city cohort. Pediatr Allergy Immunol; 21: 260–267. |
[5] | USEPA, (2008). United States Environmental Protection Agency, Office of Environmental Information, Emergency Planning and Community Right-to Know Act – Section 313: Guidance for Reporting Toxic Chemicals: Polycyclic Aromatic Compounds Category, EPA 260-B-01-03, Washington, DC. |
[6] | Maliszewska-Kordybach, B (1999). Sources, Concentrations, Fate and Effects of Polycyclic Aromatic Hydrocarbons (PAHs) in the Environment. Part A: PAHs in Air. Polish Journal of Environmental Studies; (8), 3, 131-136. |
[7] | Ravindra K, Sokhi R, Grieken, RV (2008). Atmospheric polycyclic aromatic hydrocarbons: Source attribution, emission factors and regulation. Atmospheric Environment; 42, 2895-2921. |
[8] | Abrantes R, Assunção JV ,Nóbrega RB (2004). Emission of polycyclic aromatic hydrocarbons from light-duty diesel vehicles exhaust. Atmospheric Environment;38: 1631-1640. |
[9] | Ravindra K, Wauters E, Taygi, SK, Mor, S , Van Grieken R (2006). Assessment of air quality after the implementation of CNG as fuel in public transport in Delhi, India. Environmental Monitoring and Assessment; 115: 405–417. |
[10] | Harrison MR, Smith DJT, Luhana L (1996). Source apportionment of atmospheric polycyclic aromatic hydrocarbons collected from an urban location in Birmingham, UK. Environ Sci Technol;30(3):825–32. |
[11] | Nielsen T (1996). Traffic contribution of polycyclic aromatic hydrocarbons in the center of a large city. Atmos Environ; 30:3481–90. |
[12] | Rogge WF, Hildermann LM, Mazurek MA, Cass GR (1993). Sources of fine organic aerosol. 2. Non-catalyst and catalyst-equipped automobiles and heavy-duty diesel trucks. Environ Sci Technol; 27:636–51. |
[13] | Agency for Toxic Substances and Disease Registry (1995). U.S. Department of Health and Human Services. Toxicological profile for polycyclic aromatic hydrocarbons (PAHs). Atlanta. |
[14] | Downs SH, Schindler C, Liu LJ (2007). Reduced exposure to PM10 and attenuated age-related decline in lung function. N Engl J Med; 357: 2338–47. |
[15] | McCreanor J, Cullinan P, Nieuwenhuijsen MJ (2007). Respiratory effects of exposure to diesel traffic in persons with asthma. N Engl J Med; 357: 2348–58. |
[16] | Morgenstern V, Zutavern A, Cyrys J (2008). Atopic diseases, allergic sensitization, and exposure to trafficrelated air pollution in children. Am J RespirCrit Care Med; 177: 1331–7. |
[17] | Diaz-Sanchez D, Tsien A, Fleming J, Saxon A (1997). Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern. J Immunol;158(5):2406-13. |
[18] | Ngoc LP, Gold DR, Tzianabos AO, Weiss ST, Celedon JC, (2005). Cytokines, allergy and asthma. Curr Opin Allergy Clin Immunol;5:161-6. |
[19] | GINA (Global Initiative for Asthma),(2012). Available at http://www.ginasthma.org/local/uploads/files/GINA_Pocket_April20_1.pdf. |
[20] | GINA (Global Initiative for Asthma)) (2008). ‘GINA Report, Global Strategy for Asthma Management and Prevention’ GINA accessed athttp://www.ginasthma.com/GuidelinesResources.asp?l1=2&l2=0. |
[21] | Van Schooten FJ, Moonen EJ, van der Wal L, Levels P, Kleinjans JC (1997).Determination of polycyclic aromatic hydrocarbons (PAH) and their metabolites in blood, feces, and urine of rats orally exposed to PAH contaminated soils. Arch Environ Contam Toxicol; 33(3):317-22. |
[22] | Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten P, Gustafsson R, Jensen, Johnson DC, MacIntyre N, McKay R, Navajas D,. Pedersen OF, Pellegrino R, Viegi G and Wanger J (2005). Standardisation of spirometry. EurRespir J; 26: 319–338. |
[23] | AL-Daghri NM (2008). Serum polycyclic aromatic hydrocarbons among children with and without asthma: correlation to environmental and dietary factors. International Journal of Occupational Medicine and Environmental Health; 21(3):211 – 17. |
[24] | Suresh R, Shally A, Mahd AA, Patel DK, Singh VK, and Rita M (2009). Assessment of association of exposure to polycyclic aromatic hydrocarbons with bronchial asthma and oxidative stress in children: A case control study. Indian J Occup Environ Med; 13(1): 33–37. |
[25] | Al-Daghri, NM, Alokail MS, Abd-Alrahman SH, Draz HM, Yakout SM, and Clerici M (2013). Polycyclic aromatic hydrocarbon exposure and pediatric asthma in children: a case–control study. Environmental Health; 12:1. |
[26] | Lu H, Zhu L (2007). Pollution patterns of polycyclic aromatic hydrocarbons in tobacco smoke. J Hazard Mater;139 (2): 193–98. |
[27] | Ding YS, Yan XJ, Jain RB, Lopp E, Tavakoli A, Polzin GM, (2006). Determination of 14 polycyclic aromatic hydrocarbons in mainstream smoke from US brand and non-US brand cigarettes. Environ Sci .Technol;40(4):1133–8. |
[28] | Ding YS, Ashley DL, Watson CH (2007). Determination of 10 carcinogenic polycyclic aromatic hydrocarbons in mainstream cigarette smoke. J Agric Food Chem; 55:5966–73. |
[29] | Lu H, Amagai T, Ohura T (2011). Comparison of polycyclic aromatic hydrocarbon pollution in Chinese and Japanese residential air. Journal of Environmental Sciences; 23(9) 1512–17. |
[30] | Miller RL, Garfinkel R, Horton M, Camann D, Perera FP, Whyatt RM, et al. ( 2004) . Polycyclic aromatic hydrocarbons, environmental tobacco smoke, and respiratory symptoms in an inner-city birth cohort. Chest;126:1071–8. |
[31] | Leem JH, Kim JH, Lee KH, Hong Y, Lee KH, Kang D, et al (2005). Asthma attack associated with oxidative stress by exposure to ETS and PAH. J Asthma; 42 (6): 463–7. |
[32] | Zalata A, Yahia S, El-Bakary A, Elsheikha HM(2007). Increased DNA damage in children caused by passive smoking as assessed by comet assay and oxidative stress. Mutat Res; 629(2):140–7. |
[33] | Barraza-Villarreal A, Escamilla-Nuñez MC, Schilmann A, Hernandez-Cadena L, Li Z, Romanoff L, Sjödin A,et al. (2014). Lung function, airway inflammation, and polycyclic aromatic hydrocarbons exposure in mexican schoolchildren: a pilot study. J Occup Environ Med; 56 (4): 415-9. |
[34] | Tager IB (1999). Air Pollution and Lung Function Growth Is It Ozone? Am J Respir Crit Care Med; 160: 387–89. |
[35] | Moshammer H, Hutter HP, Hauck H, Neuberger M (2006). Low levels of air pollution induce changes of lung function in a panel of schoolchildren. EurRespir J; 27:1138–1143. |
[36] | Rolfe FG, Hughes JM, Armour CL, Sewell WA (1992). Inhibition of interleukin-5 gene expression by dexamethasone. lmmunol, 77:494-499. |
[37] | Morgenstern V, Zutavern A, Cyrys J, Brockow I, Koletzko S, Kramer U, Behrendt H, Herbarth O, von Berg A, Bauer CP, Wichmann HE, Heinrich J (2008). Atopic diseases, allergic sensitization, and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med; 177:1331–1337. |
[38] | Nel AE, Diaz-Sanchez D, Ng D, Hiura T, Saxon A (1998). Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J Allergy Clin Immunol; 102:539–554. |
[39] | Takenaka H, Zhang K, Diaz-Sanchez D, Tsien A, Saxon A (1995).Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol; 95:103–15. |
[40] | Davoodi P, Mahesh PA, Holla AD, Vijayakumar GS, Jayaraj BS, Chandrashekara S, Ramachandra NB (2012). Serum levels of interleukin-13 and interferon-gamma from adult patients with asthma in Mysore, Cytokine; 60(2):431-7. |
[41] | Deng WP, Nickloff JA (1992): Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Analytical Biochem; 200:81–88. |
[42] | Madhankumar AB, Mintz A, Debinski W (2002). Alanine - scanning mutagenesis of _-helix D segment of interleukin-13 reveals new functionally important residues of the cytokine. J Biol Chem; 277:43194–43205. |
[43] | Jain E, Bairoch A, Duvaud S, Phan I, Redaschi N, et al.(2009). Infrastructure for the life sciences: design and implementation of the Uni Prot website. BMC Bioinformatics, 10:136. http://www.uniprot.org/uniparc. |
[44] | Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, et al. (2010). Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature;464:1367–1370. |
[45] | Fahy JV (2002). Goblet cell and mucin gene abnormalities in asthma. Chest ; 122(Suppl.):320S–326S. |
[46] | Munitz A, Brandt EB, Mingler M, Finkelman FD, Rothenberg (2008). Distinct roles for IL-13 and IL-4 via IL-13 receptor _1 and the type II IL-4receptor in asthma pathogenesis. Poceedings of the National Academy of Sciences; 105:7240 –724. |
[47] | Krishnaswamy G, Liu MC, Su SN, Kumai M, Xiao HQ, Marsh DG, Huang SK(1993). Analysis of cytokine transcripts in the broncho-alveolar lavage cells of patients with asthma. Am J Respir Cell MolBiol; 9(3):279-286. |
[48] | Huang SK, Krishnaswamy G, Su SN, Xiao HQ, Liu MC (1994).Qualitative and quantitative analysis of cytokine transcripts in the bronchoalveolar lavage cells of patients with asthma. Ann N Y AcadSc; 725:110-117. |
[49] | De Diego A, Martinez E, Perpina M, Nieto L, Compte L, Macian V, Senent L (2005). Airway inflammation and cough sensitivity in cough-variant asthma. Allergy; 60(11): 1407-1411. |
[50] | Lehtimaki L, Kankaanranta H, Saarelainen S, Turjanmaa V, Moilanen E ( 2005). Peripheral inflammation in patients with asthmatic symptoms but normal lung function. J Asthma; 42(7): 605-609. |
[51] | Simpson JL, Wood LG, Gibson PG (2005). Inflammatory mediators in exhaled breath, induced sputum and saliva. Clin Exp Allergy;35(9):1180-1185. |